These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22135475)

  • 1. Bayesian Experimental Design for Long-Term Longitudinal HIV Dynamic Studies.
    Huang Y; Wu H
    J Stat Plan Inference; 2008 Jan; 138(1):105-113. PubMed ID: 22135475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.
    Huang Y; Liu D; Wu H
    Biometrics; 2006 Jun; 62(2):413-23. PubMed ID: 16918905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of long-term HIV dynamic studies using semiparametric mixed-effects models.
    Huang Y; Park JG; Zhu Y
    Biom J; 2008 Aug; 50(4):528-40. PubMed ID: 18615413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian Approach in Differential Equation Dynamic Models Incorporating Clinical Factors and Covariates.
    Huang Y
    J Appl Stat; 2010 Feb; 37(2):181-199. PubMed ID: 20445811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors.
    Huang Y; Wu H; Acosta EP
    Biom J; 2010 Aug; 52(4):470-86. PubMed ID: 20661953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical methods for HIV dynamic studies in AIDS clinical trials.
    Wu H
    Stat Methods Med Res; 2005 Apr; 14(2):171-92. PubMed ID: 15807150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian analysis of nonlinear mixed-effects mixture models for longitudinal data with heterogeneity and skewness.
    Lu X; Huang Y
    Stat Med; 2014 Jul; 33(16):2830-49. PubMed ID: 24623529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESTIMATION OF CONSTANT AND TIME-VARYING DYNAMIC PARAMETERS OF HIV INFECTION IN A NONLINEAR DIFFERENTIAL EQUATION MODEL.
    Liang H; Miao H; Wu H
    Ann Appl Stat; 2010 Mar; 4(1):460-483. PubMed ID: 20556240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of long-term HIV dynamics using semi-parametric non-linear mixed-effects models.
    Wu H; Zhang JT
    Stat Med; 2002 Dec; 21(23):3655-75. PubMed ID: 12436462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models.
    Ding AA; Wu H
    Biostatistics; 2001 Mar; 2(1):13-29. PubMed ID: 12933554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Bayesian inference for linear, nonlinear and semiparametric mixed-effects models with skew-normality and measurement errors in covariates.
    Huang Y; Chen R; Dagne G
    Int J Biostat; 2011; 7(1):8. PubMed ID: 22848189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES().
    Huang Y; Wu H; Holden-Wiltse J; Acosta EP
    Ann Appl Stat; 2011; 5(1):551-577. PubMed ID: 23162677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piecewise mixed-effects models with skew distributions for evaluating viral load changes: A Bayesian approach.
    Huang Y; Dagne GA; Zhou S; Wang Z
    Stat Methods Med Res; 2015 Dec; 24(6):730-46. PubMed ID: 22045781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.
    Labbé L; Verotta D
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):519-42. PubMed ID: 16786410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skew-normal Bayesian nonlinear mixed-effects models with application to AIDS studies.
    Huang Y; Dagne G
    Stat Med; 2010 Oct; 29(23):2384-98. PubMed ID: 20603815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.
    Huang Y; Dagne G; Wu L
    Stat Med; 2011 Oct; 30(24):2930-46. PubMed ID: 21805486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.
    Wu H; Huang Y; Acosta EP; Rosenkranz SL; Kuritzkes DR; Eron JJ; Perelson AS; Gerber JG
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):272-83. PubMed ID: 15980686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.